Oramed Pharma (ORMP) Receives Additional Licensing Agreement-Related Milestone from HTIT

October 6, 2016 8:46 AM EDT
Get Alerts ORMP Hot Sheet
Trade ORMP Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) announced it has received an additional milestone payment of $4 million from Hefei Tianhui Incubator of Technologies Co. Ltd. (HTIT). This milestone is part of a previously-announced license and investment agreement between Oramed and HTIT, and follows recent milestone payments of $4 million and $6.5 million.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Corporate News

Add Your Comment